Cargando…

More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing

BACKGROUND: There are substantial global differences in the preference for mercaptopurine (MP) or its prodrug azathioprine (AZA) as first-choice thiopurine to treat inflammatory bowel diseases. Studies comparing both agents are scarce. Our aim was to compare AZA and MP in thiopurine-naive patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Broekman, Mark M. T. J., Coenen, Marieke J. H., van Marrewijk, Corine J., Wanten, Geert J. A., Wong, Dennis R., Verbeek, Andre L. M., Klungel, Olaf H., Hooymans, Piet M., Guchelaar, Henk-Jan, Scheffer, Hans, Derijks, Luc J. J., de Jong, Dirk J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Original Clinical Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598908/ https://www.ncbi.nlm.nih.gov/pubmed/28644183 http://dx.doi.org/10.1097/MIB.0000000000001163

Ejemplares similares

Patients’ beliefs about medicine are associated with early thiopurine discontinuation in patients with inflammatory bowel diseases
por: Broekman, Mark M.T.J., et al.
Publicado: (2018)

Genotype-Guided Thiopurine Dosing Does not Lead to Additional Costs in Patients With Inflammatory Bowel Disease
por: Sluiter, Reinier L, et al.
Publicado: (2019)

Risk factors for thiopurine‐induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype
por: Broekman, M. M. T. J., et al.
Publicado: (2017)

Azathioprine, Mercaptopurine, and 5-Aminosalicylic Acid Affect the Growth of IBD-Associated Campylobacter Species and Other Enteric Microbes
por: Liu, Fang, et al.
Publicado: (2017)

Implications of Tioguanine Dosing in IBD Patients with a TPMT Deficiency
por: Deben, Debbie S., et al.
Publicado: (2023)

Acute Pancreatitis Induced by Azathioprine and 6-mercaptopurine Proven by Single and Low Dose Challenge Testing in a Child with Crohn Disease
por: Yi, Geum-Chae-Won, et al.
Publicado: (2012)

Harmful Effects of the Azathioprine Metabolite 6-Mercaptopurine in Vascular Cells: Induction of Mineralization
por: Prüfer, Jasmin, et al.
Publicado: (2014)

Pancreatitis associated with azathioprine and 6-mercaptopurine use in Crohn’s disease: a systematic review
por: Gordon, Morris, et al.
Publicado: (2020)

Adherence to Azathioprine/6-Mercaptopurine in Children and Adolescents with Inflammatory Bowel Diseases: A Multimethod Study
por: Alsous, Mervat M., et al.
Publicado: (2020)

Personalised therapy during preconception and gestation in SLE: usefulness of 6-mercaptopurine metabolite levelswith azathioprine
por: Lambert-Fliszar, Francisca, et al.
Publicado: (2021)

6-Mercaptopurine: apparent lack of relation between prescribed dose and biological effect in children with leukaemia.
por: Herber, S., et al.
Publicado: (1982)

Commensal bacteria promote azathioprine therapy failure in inflammatory bowel disease via decreasing 6-mercaptopurine bioavailability
por: Yan, Yuqing, et al.
Publicado: (2023)

Incidence and determinants of hematotoxicity in acute lymphoblastic leukemia children who received 6-mercaptopurine based maintenance therapy in Addis Ababa, Ethiopia
por: Ali, Awol Mekonnen, et al.
Publicado: (2023)

Patterns of 6-mercaptopurine and azathioprine maintenance therapy among a cohort of commercially insured individuals diagnosed with Crohn’s disease in the United States
por: Lund, Jennifer L, et al.
Publicado: (2013)

Meta-analysis of the impact of thioprine S-methyltransferase polymorphisms on the tolerable 6-mercaptopurine dose considering initial dose and ethnic difference
por: Kim, Myeong Gyu, et al.
Publicado: (2016)

Persistently normal blood tests in patients taking methotrexate for RA or azathioprine for IBD: a retrospective cohort study
por: Fraser, Simon DS, et al.
Publicado: (2022)

Infliximab in young paediatric IBD patients: it is all about the dosing
por: Jongsma, Maria M. E., et al.
Publicado: (2020)

Genetic variants of genes involved in thiopurine metabolism pathway are associated with 6-mercaptopurine toxicity in pediatric acute lymphoblastic leukemia patients from Ethiopia
por: Ali, Awol Mekonnen, et al.
Publicado: (2023)

Preemptive TPMT Genotyping and Adherence to Genotype-Based Therapeutic Recommendations Reduces the Healthcare Cost in Patients Receiving Azathioprine or 6-Mercaptopurine for Autoimmune Diseases
por: Valdez-Acosta, Sarahí, et al.
Publicado: (2023)

The Pharmacoeconomic Benefits of Pemetrexed Dose Individualization in Patients With Lung Cancer
por: de Rouw, Nikki, et al.
Publicado: (2022)

Azathioprine-induced Myelotoxicity After Switching Mesalazine Compound
por: Barnhoorn, Marieke C, et al.
Publicado: (2021)

Histological remission of autoimmune hepatitis after the addition of allopurinol and azathioprine dose reduction
por: Guedes, Ana Luiza Vilar, et al.
Publicado: (2017)

Low-Dose Azathioprine in Combination with Allopurinol: The Past, Present and Future of This Useful Duo
por: Turbayne, Alexander Keith, et al.
Publicado: (2022)

Two Brothers with Skewed Thiopurine Metabolism in Ulcerative Colitis Treated Successfully with Allopurinol and Mercaptopurine Dose Reduction
por: Hoentjen, Frank, et al.
Publicado: (2011)

Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine
por: Singh, Balraj, et al.
Publicado: (2021)

Low-dose azathioprine is effective in maintaining remission among Chinese patients with Crohn’s disease
por: Wu, Jianghong, et al.
Publicado: (2013)

Childhood lymphoblastic leukaemia: sex difference in 6-mercaptopurine utilization.
por: Lilleyman, J. S., et al.
Publicado: (1984)

Long-term effect of stents eluting 6-mercaptopurine in porcine coronary arteries
por: Ruiter, Matthijs S., et al.
Publicado: (2016)

Deciphering the vedolizumab dosing conundrum in IBD: when less is more
por: Adolph, Timon Erik, et al.
Publicado: (2022)

Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC): An investigator-initiated, open, multicenter, parallel-arm, randomised controlled trial
por: Kiszka-Kanowitz, Marianne, et al.
Publicado: (2022)

The effects of 6-mercaptopurine nucleotide derivatives on the growth and survival of 6-mercaptopurine-sensitive and -resistant cell culture lines.
por: Johnston, H. P., et al.
Publicado: (1985)

On the Action of Methotrexate and 6-Mercaptopurine on M. avium Subspecies paratuberculosis
por: Greenstein, Robert J., et al.
Publicado: (2007)

Therapy of Acute Leukaemia: Comparison of Initial Treatment with 6-Mercaptopurine Alone and in Combination with Steroids
por: Bridges, J. M., et al.
Publicado: (1962)

The effect of folate supplements on 6-mercaptopurine remission maintenance therapy in childhood leukaemia.
por: Lennard, L., et al.
Publicado: (1986)

EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: THE EFFECT OF 6-MERCAPTOPURINE
por: Hoyer, Leon W., et al.
Publicado: (1962)

ANTAGONISTIC EFFECTS OF 6-MERCAPTOPURINE AND COENZYME A ON MITOCHONDRIA AND MITOSIS IN TISSUE CULTURE
por: Biesele, John J.
Publicado: (1955)

Low-dose azathioprine effectively improves mucosal healing in Chinese patients with small bowel Crohn's disease
por: Yu, Li Fen, et al.
Publicado: (2014)

Azathioprine dosing and metabolite measurement in pediatric inflammatory bowel disease: does one size fit all?
por: Walker, Rebecca, et al.
Publicado: (2019)

Intracellular metabolites of mercaptopurine in children with lymphoblastic leukaemia: a possible indicator of non-compliance?
por: Lennard, L., et al.
Publicado: (1995)

ENHANCEMENT OF ANTIBODY SYNTHESIS BY 6-MERCAPTOPURINE
por: Chanmougan, Devendrathan, et al.
Publicado: (1966)

Cannot write session to /tmp/vufind_sessions/sess_oh13oh2jp2gajc1osbhanieg30